Home » Pfizer Calls Early End to Celebrex Safety Study in Children
Pfizer Calls Early End to Celebrex Safety Study in Children
Pfizer terminated a long-term safety study of its blockbuster painkiller Celebrex in juvenile arthritis patients, citing difficulties in recruiting patients and a low rate of adverse events.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May